<DOC>
	<DOCNO>NCT02251860</DOCNO>
	<brief_summary>ARATA prospective , non-interventional , multi-center , observational study Germany evaluate long-term effectiveness tolerability subcutaneously administer RoActemra/Actemra ( tocilizumab ) patient rheumatoid arthritis daily clinical practice . Participants follow observation period 2 year initial injection .</brief_summary>
	<brief_title>An Observational Study Evaluate Long-Term Effectiveness Tolerability RoActemra®/Actemra® Administered Subcutaneously Patients With Rheumatoid Arthritis Everyday Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Aged &gt; /= 18 year Informed consent Treatment naive RoActemra/Actemra ( tocilizumab ) Participation interventional clinical trial rheumatoid arthritis time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>